Show an ad over header. AMP

I am the FIRST!!!

U.S. bans imports of cotton, other products from Xinjiang made with forced labor

U.S. Customs and Border Protection issued a series of orders on Monday barring imports of cotton, apparel, hair products, computer parts and other goods from China's Xinjiang region due to the government's "illicit, inhumane, and exploitative practices of forced labor."

Why it matters: The Trump administration is taking an increasingly aggressive approach to human rights abuses in Xinjiang, where the Chinese government is engaged in a sweeping campaign of demographic and cultural genocide against Uighur Muslims and other ethnic minorities.


Details: The CBP orders apply to the following imports ...

  1. All products made with labor from the Lop County No. 4 Vocational Skills Education and Training Center in Xinjiang
  2. Hair products made in the Lop County Hair Product Industrial Park in Xinjiang
  3. Apparel produced by Yili Zhuowan Garment Manufacturing Co., Ltd. and Baoding LYSZD Trade and Business Co., Ltd in Xinjiang
  4. Cotton produced and processed by Xinjiang Junggar Cotton and Linen Co., Ltd. in Xinjiang
  5. Computer parts made by Hefei Bitland Information Technology Co., Ltd. in Anhui

What they're saying: "The Trump administration will not stand idly by and allow foreign companies to subject vulnerable workers to forced labor while harming American businesses that respect human rights and the rule of law,” Acting CBP Commissioner Mark Morgan said in a statement.

  • “Today’s Withhold Release Orders send a clear message to the international community that we will not tolerate the illicit, inhumane, and exploitative practices of forced labor in U.S. supply chains.”

The big picture: President Trump told Axios in June that he previously held off on sanctioning officials and entities involved in the detention camps because doing so would have interfered with his trade deal with Beijing.

  • In July, the U.S. sanctioned Chinese Communist Party officials, the Xinjiang Public Security Bureau and the Xinjiang Production and Construction Corps (XPCC) for their role in constructing and operating massive "re-education" camps, where over 1 million Uighurs have been detained.
  • The XPCC, a paramilitary organization, is involved in the production of one-third of China's cotton, and in 2014, XPCC-controlled interests comprised 17% of Xinjiang's economy.

Go deeper: U.S. seizes $800,000 shipment of Xinjiang products made with human hair

regular 4 post ff

infinite scroll 4 pff

Biden's electric vehicle push puts new focus on jobs

President Biden's swift effort to re-establish stricter fuel efficiency mandates, along with his broader push toward vehicle electrification, is as much about creating new jobs as it is protecting the environment.

Why it matters: The U.S. lags far behind the rest of the world in electric vehicle adoption. Catching up will require big investments in EV production — including battery cell manufacturing and mining of raw materials — to avoid dependence on imports and foreign supply chains.

Keep reading...Show less

Hundreds of Biden staffers receive COVID vaccine

A week into the job, President Biden's White House medical team has administered the coronavirus vaccine to several hundred staffers — and aims to vaccinate all in-person staff over the next few weeks, officials tell Axios.

Why it matters: The new administration is ramping up steps to protect President Biden — but also to protect all staff working inside the complex. The administration is also requiring daily employee COVID tests and N95 masks at all times.

Keep reading...Show less

Pfizer and Moderna expect to double vaccine shipments by spring

Moderna and Pfizer plan to significantly boost vaccine shipments to the U.S. government by this spring, according to written testimony from company executives released Tuesday ahead of a House committee hearing on vaccines.

Where it stands: Pfizer expects to increase its weekly vaccine delivery from 4-5 million doses at the start of February to more than 13 million doses by mid-March, said John Young, Pfizer's chief business officer.

Keep reading...Show less

New Alzheimer's drug may be a catastrophe in the making

The FDA’s approval of a new Alzheimer’s treatment — the first one in almost two decades — should have been a cause for celebration. Instead, it has become a scientific and financial mess.

Why it matters: Experts from all corners of the health care world fear the FDA’s decision will undermine medical standards, explode the federal budget and fill millions of desperate people with false hope.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;